Loading clinical trials...
Loading clinical trials...
Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning in Older Individuals With Mild Cognitive Impairment
This study aims to explore the potential of using machine learning (ML) algorithms to predict Diabetes type2, based on oral health and demographic data. The objective is to evaluate the effectiveness of various ML models and identify the most relevant oral health indicators for predicting type 2 diabetes in individuals with mild cognitive impairment aged 60 and above.
This cross-sectional study utilizes oral health and demographic data from the Swedish National Study on Aging and Care (SNAC-B). Participants aged 60 years or older with Mild Cognitive Impairment will be included in the analysis. The data will be used to develop and evaluate machine learning models for predicting type 2 diabetes. Objectives: 1. Primary Objective: To assess the potential of oral health parameters for binary classification of type 2 diabetes or not. 2. Secondary Objective: To identify the most influential oral health parameters contributing to type 2 diabetes predictions. 3. Tertiary Objective: To compare the performance of Random Forest (RF), Support Vector Machine (SVM), and CatBoost (CB) classifiers in predicting type 2 diabetes using oral health data.
Age
60 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Department of Health, Blekinge Institute of Technology
Karlskrona, Sweden
Start Date
August 30, 2025
Primary Completion Date
December 1, 2026
Completion Date
July 1, 2027
Last Updated
May 20, 2025
2,000
ESTIMATED participants
A dataset comprising participants withT2D will be used to evaluate the classification performance of various machine learning techniques.
OTHER
Lead Sponsor
Blekinge Institute of Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06671587